ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer
Targeted Oncology
◽
10.1007/s11523-021-00823-4
◽
2021
◽
Author(s):
Jiani Wang
◽
Qingyuan Zhang
◽
Qiao Li
◽
Yuxin Mu
◽
Jing Jing
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase I
◽
Histone Deacetylase Inhibitor
◽
Phase I Study
◽
Metastatic Breast
◽
Efficacy Analysis
◽
Hormone Receptor Positive
◽
Deacetylase Inhibitor
◽
Chinese Postmenopausal Women
Download Full-text
Related Documents
Cited By
References
Phase I-II study of the histone deacetylase inhibitor (HDACi) vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer (MBC): New York Cancer Consortium trial P7703.
10.1158/0008-5472.sabcs-404
◽
2009
◽
Cited By ~ 4
Author(s):
B Ramaswamy
◽
K Bhalla
◽
B Cohen
◽
C Pellegrino
◽
D Hershman
◽
...
Keyword(s):
Breast Cancer
◽
New York
◽
Metastatic Breast Cancer
◽
Phase I
◽
Histone Deacetylase
◽
Histone Deacetylase Inhibitor
◽
Metastatic Breast
◽
Deacetylase Inhibitor
Download Full-text
Abstract CT330: Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
10.1158/1538-7445.am2015-ct330
◽
2015
◽
Cited By ~ 3
Author(s):
Payal D. Shah
◽
Mary E. Moynahan
◽
Shanu Modi
◽
Nicola Hamilton
◽
Betty Ann Caravella
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase I
◽
Aromatase Inhibitor
◽
Hormone Receptor
◽
Phase I Study
◽
Metastatic Breast
◽
Hormone Receptor Positive
Download Full-text
A phase I study of palbociclib (PALBO) plus everolimus (EVE) and exemestane (EXE) in hormone-receptor positive (HR+)/HER2- metastatic breast cancer (MBC) after progression on a CDK4/6 inhibitor (CDK4/6i): safety, tolerability and pharmacokinetic (PK) analysis.
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.1068
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. 1068-1068
Author(s):
Romualdo Barroso-Sousa
◽
Hao Guo
◽
William Thomas Barry
◽
Arlindo R. Ferreira
◽
Rebecca Rees
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase I
◽
Hormone Receptor
◽
Phase I Study
◽
Metastatic Breast
◽
Hormone Receptor Positive
Download Full-text
Phase I study of everolimus, letrozole, and trastuzumab in patients with hormone receptor-positive metastatic breast cancer or other solid tumors
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-20-2878
◽
2020
◽
pp. clincanres.2878.2020
Author(s):
Alexej Ballhausen
◽
Jennifer J. Wheler
◽
Daniel D. Karp
◽
Sarina A. Piha-Paul
◽
Siqing Fu
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase I
◽
Solid Tumors
◽
Hormone Receptor
◽
Phase I Study
◽
Metastatic Breast
◽
Hormone Receptor Positive
Download Full-text
Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-021-04245-x
◽
2021
◽
Author(s):
Filipa Lynce
◽
James T. Williams
◽
Meredith M. Regan
◽
Craig A. Bunnell
◽
Rachel A. Freedman
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase I
◽
Phase I Study
◽
Metastatic Breast
◽
Weekly Paclitaxel
Download Full-text
A Phase I Study of Pemetrexed (ALIMTA) and Cyclophosphamide in Patients with Locally Advanced or Metastatic Breast Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-05-2829
◽
2006
◽
Vol 12
(23)
◽
pp. 7071-7078
◽
Cited By ~ 10
Author(s):
Christian Dittrich
◽
Lubos Petruzelka
◽
Pavel Vodvarka
◽
Margit Gneist
◽
Filip Janku
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase I
◽
Phase I Study
◽
Locally Advanced
◽
Metastatic Breast
Download Full-text
Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients
Clinical Breast Cancer
◽
10.1016/j.clbc.2015.11.003
◽
2016
◽
Vol 16
(2)
◽
pp. 82-86
◽
Cited By ~ 18
Author(s):
Winston W. Tan
◽
Jacob B. Allred
◽
Alvaro Moreno-Aspitia
◽
Donald W. Northfelt
◽
James N. Ingle
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase I
◽
Cancer Patients
◽
Phase I Study
◽
Metastatic Breast
◽
Breast Cancer Patients
Download Full-text
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Breast Cancer Research and Treatment
◽
10.1007/s10549-009-0666-9
◽
2009
◽
Vol 119
(3)
◽
pp. 673-683
◽
Cited By ~ 55
Author(s):
Ursula Wiedermann
◽
C. Wiltschke
◽
J. Jasinska
◽
M. Kundi
◽
R. Zurbriggen
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Immune Responses
◽
Phase I
◽
Phase I Study
◽
Peptide Vaccine
◽
Metastatic Breast
◽
Her 2
Download Full-text
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)
Breast Cancer Research and Treatment
◽
10.1007/s10549-017-4261-1
◽
2017
◽
Vol 164
(2)
◽
pp. 359-369
◽
Cited By ~ 38
Author(s):
Cornelia von Hagens
◽
Ingeborg Walter-Sack
◽
Maren Goeckenjan
◽
Julia Osburg
◽
Brigitte Storch-Hagenlocher
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase I
◽
Phase I Study
◽
Metastatic Breast
Download Full-text
453 Phase I study of vinorelbine (VRL) alternating i.v. and oral in combination with docetaxel (DTX) as 1st line chemotherapy (CT) of metastatic breast cancer (MBC)
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(03)90485-x
◽
2003
◽
Vol 1
(5)
◽
pp. S138
◽
Cited By ~ 1
Author(s):
M. Campone
◽
P. Fumoleau
◽
A. Tekiela
◽
P. Koralewski
◽
J. Bonneterre
◽
...
Keyword(s):
Breast Cancer
◽
Metastatic Breast Cancer
◽
Phase I
◽
Phase I Study
◽
Metastatic Breast
◽
Line Chemotherapy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close